Luiz Fernando Lopes
Research Subjects
Luiz Fernando Lopes has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Beatriz De Camargo
Pediatric Department, Hospital A.C. Camargo, São Paulo, Brazil
1 shared publication- Beatriz de Camargo
Research Center, Instituto Nacional do Cancer, Rio de Janeiro, Brazil
1 shared publication Elizabeth Morinaka
Oncology Department, Hospital Hélio Angotti, Uberaba, Minas Gerais, Brazil
1 shared publicationMiriam Dondonis
Pediatric Department, Hospital Santo Antonio, Porto Alegre, Rio Grande do Sul, Brazil
1 shared publicationRicardo Chazan
Department of Gynecology, Cancer Hospital, A.C. Camargo, São Paulo, Brazil
1 shared publicationRogerio Agenor de Araujo
Oncology Department, Universidade Federal de Uberlǎndia, Minas Gerais, Brazil
1 shared publication
Latest Publications
- 7 April 1999
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 32 (5) , 377-381
Endodermal sinus tumor of the vagina in children
- 7 April 1999
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 32 (5) , 377-381
Endodermal sinus tumor of the vagina in children
- 1 November 1995
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 25 (5) , 396-399
Response to high‐dose cisplatin and etoposide in advanced germ cell tumors in children: Results of the Brazilian germ cell tumor study
A trial was undertaken to assess the efficacy and toxicity of high-dose cisplatin and etoposide in children with newly diagnosed advanced malignant germ cell tumors. A total of eleven children and adolescents were treated with courses of high dose cisplatin 30 mg/m2/day and etoposide 120 mg/m2/day in five day cycles at 21 day intervals. There were eight girls and three boys, aged between 1 and 16 years (median: 120 months). Of nine unresectable tumors, six were in complete remission after three cycles and were completely resected. All patients are alive (median follow-up 17 months). Preliminary results shows that high dose cisplatin and etoposide is effective in controlling advanced malignant germ cell tumor.
- 1 November 1995
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 25 (5) , 396-399
Response to high‐dose cisplatin and etoposide in advanced germ cell tumors in children: Results of the Brazilian germ cell tumor study
A trial was undertaken to assess the efficacy and toxicity of high-dose cisplatin and etoposide in children with newly diagnosed advanced malignant germ cell tumors. A total of eleven children and adolescents were treated with courses of high dose cisplatin 30 mg/m2/day and etoposide 120 mg/m2/day in five day cycles at 21 day intervals. There were eight girls and three boys, aged between 1 and 16 years (median: 120 months). Of nine unresectable tumors, six were in complete remission after three cycles and were completely resected. All patients are alive (median follow-up 17 months). Preliminary results shows that high dose cisplatin and etoposide is effective in controlling advanced malignant germ cell tumor.